http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-813485-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| filingDate | 1956-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1959-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-813485-A |
| titleOfInvention | Antibiotic compositions |
| abstract | An antibiotic composition in finely divided form, useful for combatting respiratory diseases in animals, comprises a finely divided antibiotic having a particle size below 50 microns, e.g. streptomycin or dihydrostreptomycin or salts thereof, in admixture with an anti-caking agent in finely divided form, preferably below 15 microns, selected from the group consisting of a vegetable flour, a crystalline water-insoluble inorganic magnesium salt, silicon dioxide, and a water-insoluble soap. The anti-caking agent is preferably present in the range of 0.5 to 20 per cent by weight of the composition. Other antibiotics which may be used include neomycin, aureomycin, erythromycin, tetracycline, 4-amino - 3 - isoxazolidone and oxytetradine. The anti-caking agents, which are present in the compositions to facilitate application by use of a spray gun, may be supplemented, when the compositions are to be exposed to excessive moisture, by further inert anti-caking agents such as starch, calcium carbonate, calcium phosphate, and calcium chloride. Conventional stabilizers and other therapeutically active compounds may also be included in the compositions, such as streptodornase, pancreatic dornase and trypsin to reduce the thickened mucus in the respiratory tract in respiratory diseases. |
| priorityDate | 1955-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.